Revolution Medicines, Inc.
DE ˙ DB ˙ US76155X1000
135,25 € ↑2,80 (2,11%)
2026-05-29
DEL PRIS
SecurityDE:42Z / Revolution Medicines, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership4,386,791 shares
Latest Disclosed Value $ 426,615,425
UBS Group AG ownership in 42Z / Revolution Medicines, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 4,386,791 shares of Revolution Medicines, Inc. (DE:42Z) valued at $359,716,862 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 3,087,937 shares of Revolution Medicines, Inc.. This represents a change in shares of 42.06% during the quarter. The current value of the position is $593,313,483 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (42Z) in the form of stock options. The firm currently holds call options representing 7,500 of underlying shares valued at $729,375 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:42Z / Revolution Medicines, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 4,386,791 1,298,854 42.06 426,615 73.45 0.0120
2026-01-29 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 3,087,937 1,998,972 183.57 245,954 383.65 0.0399
2025-11-13 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 1,088,965 574,212 111.55 50,855 168.54 0.0080
2025-08-14 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 514,753 32,646 6.77 18,938 11.09 0.0033
2025-05-13 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 482,107 182,324 60.82 17,047 30.01 0.0031
2025-02-14 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 299,783 106,704 55.26 13,113 49.75 0.0024
2024-11-14 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 193,079 -24,684 -11.34 8,756 3.61 0.0019
2024-08-14 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 217,763 -87,216 -28.60 8,451 -14.02 0.0021
2024-05-13 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 304,979 -1,579 -0.52 9,829 11.79 0.0024
2024-02-09 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 306,558 209,399 215.52 8,792 226.96 0.0026
2023-11-09 2023-09-30 13F REVOLUTION MEDICINES COM 76155X100 97,159 -39,295 -28.80 2,689 -26.33 0.0009
2023-08-11 2023-06-30 13F REVOLUTION MEDICINES COM 76155X100 136,454 -1,907 -1.38 3,650 21.83 0.0012
2023-05-12 2023-03-31 13F REVOLUTION MEDICINES COM 76155X100 138,361 -29,282 -17.47 2,997 -24.97 0.0011
2023-02-08 2022-12-31 13F REVOLUTION MEDICINES COM 76155X100 167,643 134,940 412.62 3,993 519.07 0.0015
2022-11-10 2022-09-30 13F REVOLUTION MEDICINES COM 76155X100 32,703 -8,329 -20.30 645 -19.37 0.0003
2022-08-10 2022-06-30 13F REVOLUTION MEDICINES COM 76155X100 41,032 -49,117 -54.48 800 -65.22 0.0003
2022-05-16 2022-03-31 13F REVOLUTION MEDICINES COM 76155X100 90,149 -24,271 -21.21 2,300 -20.11 0.0008
2022-02-14 2021-12-31 13F REVOLUTION MEDICINES COM 76155X100 114,420 -2,930 -2.50 2,879 -10.81 0.0008
2021-11-15 2021-09-30 13F REVOLUTION MEDICINES COM 76155X100 117,350 116,252 10,587.61 3,228 9,122.86 0.0010
2021-08-13 2021-06-30 13F REVOLUTION MEDICINES COM 76155X100 1,098 -340 -23.64 35 -46.97 0.0000
2021-05-12 2021-03-31 13F REVOLUTION MEDICINES COM 76155X100 1,438 235 19.53 66 37.50 0.0000
2021-02-11 2020-12-31 13F REVOLUTION MEDICINES COM 76155X100 1,203 1,203 48 0.0000
2020-11-12 2020-09-30 13F REVOLUTION MEDICINES COM 76155X100 0 -4,892 -100.00 0 -100.00
2020-07-31 2020-06-30 13F REVOLUTION MEDICINES COM 76155X100 4,892 -3,479 -41.56 154 -15.85 0.0001
2020-05-01 2020-03-31 13F REVOLUTION MEDICINES COM 76155X100 8,371 8,371 183 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F REVOLUTION MEDICINES COM Call 7,500 729 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.